Galatek designs flexible, AI-enabled laboratory automation systems for life sciences and analytical chemistry. Its platforms combine intelligent software with modular hardware to automate real-world lab workflows – from routine processes to advanced research – without forcing labs to conform to rigid, one-size-fits-all systems.
FYR
FYR is revolutionizing the ability to dynamically observe disease and treatment response to produce better biomarkers, better trials, better drugs and better outcomes. FYR’s EV-Omics (EVO) platform leverages its proprietary technology, SPARCsTM, to enrich extracellular vesicles from diseased cells and reveal a treasure trove of proteins and nucleic acids. Utilizing AI-enabled multiomic insights, EVO unravels the complexity of disease mechanisms, thereby informing potential treatment options. The unparalleled view provided by FYR’s multiomics approach can transform personalized patient care, from screening through therapy selection and monitoring.
Fulgent Genetics
Fulgent is a technology-driven Biopharma services company boasting a robust portfolio of clinical diagnostic, research solutions and R&D capabilities. Our clinical diagnostic and BioPharma business units provide a wide array of services including molecular diagnostic testing, comprehensive NGS genetic testing, RNASeq, targeted DNA / RNA panels (FFPE, Liquid Biopsy, Heme), single cell and spatial analysis (10x Genomics), proteomics (Olink) and top-tier anatomic pathology laboratory services (Immunohistochemistry (IHC), RNAscope (ISH), Akoya, Flow Cytometry). These offerings are meticulously crafted to support biomarker development in immuno-Oncology research complemented with actionable diagnostic insights, ultimately enhancing the quality of patient care. With a dedicated focus on patient screening and enrollment testing, biomarker analysis, and companion diagnostics for clinical research, Pharma Clinical trials, and contract research, Fulgent’s BioPharma Services cater to the specific needs of the pharmaceutical industry. With facilities situated in the US, China, and Australia, our overarching mission is to revolutionize the genomic diagnostic landscape, positioning ourselves as a fully integrated precision medicine company poised to drive advancements in healthcare. Fulgent’s latest step forward to this commitment is approval for the largest CE-marked Clinical Exome gene panel for genetic testing, underscoring our dedication to meeting the highest standards of regulatory compliance & quality. | Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike.
Frontage Laboratories, Inc.
Frontage Laboratories, Inc., is a global Contract Research Organization (CRO) which provides integrated, science-driven, product development services from drug discovery to late phase clinical process to enable biopharmaceutical companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions. | We are a CRO providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science companies to achieve their drug development goals. We have enabled many innovator, generic and consumer health companies of all sizes to file IND, NDA, ANDA, BLA and 505(b)(2) submissions in global markets allowing for successful development of important therapies and products for patients. We are committed to providing rigorous scientific expertise to ensure the highest quality and compliance. We have successfully assisted clients to advance hundreds of molecules through development to commercial launch in global markets.
Fraunhofer IIS
The Fraunhofer-Gesellschaft, based in Germany, is the world’s leading applied research organization. Fraunhofer develops and licenses tomorrow’s technologies and serves as a RnD contractor or CRO to international industry. Fraunhofer IIS’s biomedical image analysis division exhibits their computational pathology & spatial biology solution MIKAIA® (www.mikaia.ai) as well as their preclinical CRO & pharma services. MIKAIA® contains off-the-shelf apps (HE, IHC, mIF, MSI, FISH) and can be extended using the interactive AI Author or the “plug in your own AI” API. | For over 30 years, the Audio and Media Technologies division of Fraunhofer IIS has been shaping the globally deployed standards and technologies in the fields of audio and moving picture production. Almost all consumer electronic devices, computers and mobile phones are equipped with systems and technologies from Erlangen today.
Eton Bioscience
Eton Bioscience is a San Diego-based biotechnology company founded in 2003. We support the global life science community with reliable, cost-effective molecular biology services, including DNA sequencing, oligo and gene synthesis, gene delivery, and protein and antibody solutions, backed by strong technical expertise and responsive support.
Epistem Ltd
Epistem’s oncology team has a solid reputation and extensive experience in guiding therapeutic agents through various stages, including early-stage in vitro proof of concept testing, in vivo efficacy models, and the quantification of target engagement via biomarkers to support clinical studies. Our services are available individually or as part of a comprehensive integrated package. Our analytical capabilities include histology & IHC, pharmacogenomics, advanced imaging and analysis, as well as flow cytometry & cytokine profiling, providing clients with practical and effective support for their research and development needs. We also offer additional models, such as dermatological (in vitro and in vivo), wound healing (in vitro and in vivo), inflammatory diseases (IBD), and organoid models for toxicity testing across four different species.
EpigenTek Group Inc.
EpigenTek is the leading provider of epigenetic assay kits, antibodies, reagents, and services through a complete and systematic approach. We are the first company to specialize exclusively in epigenetics and has pioneered the commercialization of many technologies commonly used today in DNA methylation, RNA methylation, histone modification, and chromatin studies.
Epigenica
At Epigenica, we build innovative products for epigenetic analysis that foster scientific breakthroughs to advance human health.
Enzo Life Sciences
Global Life Sciences Company Serving the Scientific Community for over 50 Years Enzo Life Sciences is a focused global life science company delivering innovative solutions to support biomedical research, translational science, and drug development. For more than 50 years, Enzo has been a leader in product development and technology innovation, serving academic research institutions and biopharma partners worldwide. With a comprehensive portfolio of widely cited and highly trusted quality products—including antibodies, assays, genomic probes, proteins, and biochemicals—Enzo supports a broad range of applications across genomic, protein, cellular, tissue, and small molecule analysis. Proprietary technologies and products play key roles at every stage of translational research and therapeutic development. Enzo Life Sciences’ deep scientific expertise, flexible solutions, and versatile product offerings accelerate research timelines, enabling partners to effectively and efficiently advance discovery and development efforts.